Clinical Trial Update: To Compare the Efficacy and Safety of INS068 and Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Not Adequately Controlled With Oral Antidiabetic Drugs [Phase 3]

View source ↗

Summary

A Phase 3 study comparing INS068 with insulin glargine in adults with Type 2 diabetes mellitus not adequately controlled with oral antidiabetic drugs has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• INS068
• Insulin Glargine (insulin glargine)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED